Roumen Balabanov to Time Factors
This is a "connection" page, showing publications Roumen Balabanov has written about Time Factors.
Connection Strength
0.030
-
Outcomes of natalizumab treatment within 3?years of relapsing-remitting multiple sclerosis diagnosis: a prespecified 2-year interim analysis of STRIVE. BMC Neurol. 2019 Jun 08; 19(1):116.
Score: 0.030